InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Dash Barry H, Director. Officer active across 1 companies, notably Elite Pharmaceuticals INC. Cumulatively, 2 disclosures have been published. The latest transaction was filed on 30 June 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations2 total
€16,877295,570 shares@ €0.0571100.0% of flow
Common Stock
SEC:0001324222-21-000001·
€16,877295,570 shares@ €0.05710.0036% mcap50.0% of flow
Common Stock
SEC:0001324222-21-000001:0·
2 of 2 declarations
About Dash Barry H
Barry H. Dash is a Board Member at Elite Pharmaceuticals Inc. He plays a key role in overseeing the company's operations and strategic decision-making. With experience in the pharmaceutical sector, he contributes to the strategic direction of Elite Pharmaceuticals, which focuses on developing generic drugs.
